MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q4
hinzugefügt 11.02.2026
Organovo Holdings Kurzfristige Verbindlichkeiten 2011-2026 | ONVO
Kurzfristige Verbindlichkeiten Jährlich Organovo Holdings
| 2025 | 2024 | 2023 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.74 M | 1.86 M | 3.67 M | 721 K | 1.81 M | 3.74 M | 4.66 M | 6.01 M | 4.49 M | 4.76 M | 1.89 M | 8.38 M | 22 M | 1.98 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 22 M | 721 K | 4.98 M |
Kurzfristige Verbindlichkeiten anderer Aktien in der Diagnostik & Forschung
| Name | Kurzfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Agilent Technologies
A
|
1.71 B | $ 110.28 | -2.82 % | $ 33.5 B |  USA |
 |
Enzo Biochem
ENZ
|
24.8 M | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
641 M | - | - | $ 19.8 B | USA |
 |
Akumin
AKU
|
169 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Sotera Health Company
SHC
|
250 M | $ 13.21 | -2.44 % | $ 3.75 B | USA |
 |
Check-Cap Ltd.
CHEK
|
1.81 M | - | - | $ 9.42 M |  Israel |
 |
Heska Corporation
HSKA
|
39.6 M | - | - | $ 1.31 B | USA |
|
Biodesix
BDSX
|
14.3 M | $ 14.31 | -2.02 % | $ 1.86 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
13.8 M | - | - | $ 562 M |  Britain |
 |
Burning Rock Biotech Limited
BNR
|
372 M | $ 16.41 | -11.3 % | $ 177 M |  China |
 |
BioNano Genomics
BNGO
|
22.9 M | $ 1.15 | -0.43 % | $ 6.26 M | USA |
 |
Bioventus
BVS
|
160 M | $ 9.03 | -2.48 % | $ 602 M | USA |
 |
Co-Diagnostics
CODX
|
5.75 M | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
DermTech
DMTK
|
13.4 M | - | -11.32 % | $ 2.94 M | USA |
 |
Aspira Women's Health
AWH
|
5.78 M | - | -6.19 % | $ 10.5 M | USA |
 |
DexCom
DXCM
|
2.14 B | $ 62.84 | -4.93 % | $ 24.5 B | USA |
 |
Accelerate Diagnostics
AXDX
|
66.6 M | - | -61.36 % | $ 2.46 M | USA |
 |
Global Cord Blood Corporation
CO
|
647 M | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
54.2 M | - | 1.08 % | $ 308 M | USA |
 |
Fulgent Genetics
FLGT
|
72.9 M | $ 15.54 | -5.13 % | $ 470 M | USA |
 |
Guardant Health
GH
|
303 M | $ 84.0 | -4.65 % | $ 10.5 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
8.27 M | - | -20.0 % | $ 1.06 M | USA |
 |
Castle Biosciences
CSTL
|
49.4 M | $ 24.0 | -2.83 % | $ 667 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.27 B | - | - | $ 10.7 B | USA |
 |
Charles River Laboratories International
CRL
|
1.12 B | $ 158.89 | -3.78 % | $ 7.88 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
2.28 B | $ 195.64 | -1.27 % | $ 21.7 B | USA |
 |
OpGen
OPGN
|
634 K | - | -16.95 % | $ 1.54 M | USA |
 |
DarioHealth Corp.
DRIO
|
9.32 M | $ 8.45 | - | $ 33.7 M | Israel |
 |
ICON Public Limited Company
ICLR
|
2.8 B | $ 102.3 | -0.76 % | $ 8.44 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
1.15 B | $ 561.97 | -1.98 % | $ 45.2 B | USA |
 |
Biocept
BIOC
|
5.51 M | - | -13.05 % | $ 7.29 M | USA |
 |
Illumina
ILMN
|
1.55 B | $ 117.62 | -5.45 % | $ 18.7 B | USA |
 |
PerkinElmer
PKI
|
1.33 B | - | -0.91 % | $ 14.7 B | USA |
 |
Invitae Corporation
NVTA
|
108 M | - | - | $ 21.2 M | USA |
 |
Interpace Biosciences
IDXG
|
10.6 M | $ 1.68 | -2.89 % | $ 7.37 M | USA |
 |
Medpace Holdings
MEDP
|
1.34 B | $ 452.91 | -2.94 % | $ 13.1 B | USA |
 |
Mettler-Toledo International
MTD
|
1.2 B | $ 1 233.1 | -2.91 % | $ 25.4 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
134 M | $ 4.38 | -5.19 % | $ 406 M | USA |
 |
ENDRA Life Sciences
NDRA
|
605 K | $ 4.26 | -7.19 % | $ 2.29 M | USA |
 |
NeoGenomics
NEO
|
88.3 M | $ 7.35 | -5.28 % | $ 942 M | USA |
 |
IQVIA Holdings
IQV
|
8.34 B | $ 164.54 | -2.87 % | $ 28.3 B | USA |
 |
Motus GI Holdings
MOTS
|
3.27 M | - | -34.28 % | $ 263 K | Israel |
 |
National Research Corporation
NRC
|
36.6 M | $ 17.2 | -0.95 % | $ 385 M | USA |
 |
QIAGEN N.V.
QGEN
|
544 M | - | - | $ 10.6 B |  Niderland |
 |
Natera
NTRA
|
310 M | $ 184.45 | -5.96 % | $ 18.2 B | USA |
 |
OPKO Health
OPK
|
193 M | $ 1.15 | -1.79 % | $ 798 M | USA |